The effect of uric acid on homocysteine-induced endothelial dysfunction in bovine aortic endothelial cells

Neuroendocrinology Letters

Volumn 30, Issue SUPPL.1, 2009, Pages 112-115

  Papezikova, Ivana ^a   Pekarova, Michaela ^a   Lojek, Antonín ^a   Kubala, Lukas ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

Bovine aortic endothelial cells; Endothelial dysfunction; Homocysteine; Nitric oxide; Uric acid

Indexed keywords

CALCIMYCIN; CALCIUM IONOPHORE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLUORESCENT DYE; HOMOCYSTEINE; NITRIC OXIDE; SCAVENGER; SERINE; SUPEROXIDE; URIC ACID;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; AORTA; ARTICLE; BIOAVAILABILITY; CELL STIMULATION; CONCENTRATION RESPONSE; COW; ELECTROCHEMICAL ANALYSIS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; MICROELECTRODE; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 77349101569     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Becker BF, Reinholz N, Leipert B, Raschke P, Permanetter B, Gerlach E (1991 ). Role of Uric Acid as Endogenous Radical Scavenger and Antioxidant. Chest. 100: 176S-181S.
2. Chatterjee A, Catravas JD (2008). Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vasc Pharmacol. 49: 134-140.
3. Gersch C, Palii SP, Kim KM, Angerhofer A, Johnson R, Henderson GN (2008). Inactivation of nitric oxide by uric acid. Nucleos Nucleot Nucl. 27: 967-978.
4. Govers R, Rabelink TJ (2001). Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol. 280: F193-F206.
5. Hayden MR, Tyagi SC (2004). Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metabolism. 1:10.
6. Kannelis J, Kang D-H (2005). Uric Acid as a Mediator of Endothelial Dysfunction, Inflammation, and Vascular Disease. Semin Nephrol 25: 39-42.
7. Lojek A, Pečivová J, Mačičková T, Nosál R, Papežíková I, Číž M (2008). Effect of carvedilol on the production of reactive oxygen species by HL-60 cells. Neuroendocrinol Lett. 29: 779-783.
8. Mount PF, Kemp BE, Power DA (2007). Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol 42: 271-279.
9. Papežíková I, Lojek A, Číž M (2007). A comparison of antioxidant properties of uric acid, allantoin and allantoic acid. Chem Listy. 101: s73-s310.
10. Papežíková I, Pekarová M, Chatzopoulou M, Nicolaou I, Demopoulos V, Kubala L, et al (2008). The effect of aldose reductase inhibition by JMC-2004 on hyperglycemia-induced endothelial dysfunction. Neuroendocrinol Lett. 29: 775-778.
11. Ramaswami G, Chai H, Yao Q, Lin PH, Lumsden AB, Chen C et al (2004). Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg. 40: 1216-1222.
12. Reynolds T (2007). Serum uric acid, the endothelium and hypertension: an association revisited. J Hum Hypertens. 21: 591-593.
13. Suzuki T (2006). Nitrosation of uric acid induced by nitric oxide under aerobic conditions. Nitric oxide. 16: 266-273.
14. Zhang BQ, Hu SJ, Qiu LH, Zhu JH, Xie XJ, Sun J, et al (2007). Effects of Astralagus membranaceus and its main components on the acute phase endothelial dysfunction induced by homocysteine. Vascul Pharmacol. 46: 278-285.